We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.57%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.52B
AUM Growth
+$35M
Cap. Flow
+$831M
Cap. Flow %
23.65%
Top 10 Hldgs %
38.14%
Holding
2,292
New
549
Increased
398
Reduced
416
Closed
501
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDRX
1326
DELISTED
Veradigm Inc. Common Stock
MDRX
$156K ﹤0.01%
+10,498
New +$196K
HNST icon
1327
The Honest Company
HNST
$561M
$154K ﹤0.01%
52,777
+10,622
+25% +$38.3K
COCH icon
1328
Envoy Medical
COCH
$54.3M
$153K ﹤0.01%
15,629
GSAQ
1329
DELISTED
Global Synergy Acquisition Corp. Class A Ordinary Shares
GSAQ
$153K ﹤0.01%
15,385
-2,772
-15% -$27.6K
TBSA
1330
DELISTED
TB SA Acquisition Corp Class A Ordinary Share
TBSA
$151K ﹤0.01%
15,450
+5,450
+55% +$53.3K
WBX
1331
Wallbox
WBX
$79.6M
$150K ﹤0.01%
842
-1,430
-63% -$307K
SRT
1332
DELISTED
Startek Inc.
SRT
$150K ﹤0.01%
+51,824
New +$192K
SRT
1333
PUT
DELISTED
Startek Inc.
SRT
$150K ﹤0.01%
+51,800
New +$192K
ENERU
1334
DELISTED
Accretion Acquisition Corp Unit
ENERU
$150K ﹤0.01%
15,000
DILAU
1335
DELISTED
DILA Capital Acquisition Corp. Unit
DILAU
$149K ﹤0.01%
15,000
MSOS icon
1336
CALL
AdvisorShares Pure US Cannabis ETF
MSOS
$884M
$148K ﹤0.01%
14,300
-400
-3% -$5.94K
RXRX icon
1337
Recursion Pharmaceuticals
RXRX
$1.76B
$148K ﹤0.01%
+18,243
New +$122K
FLNC icon
1338
Fluence Energy
FLNC
$2.34B
$146K ﹤0.01%
+15,437
New +$150K
AMPS
1339
DELISTED
Altus Power
AMPS
$146K ﹤0.01%
+23,115
New +$154K
VAPO
1340
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$146K ﹤0.01%
7,215
-2,658
-27% -$97.3K
FICVU
1341
DELISTED
Frontier Investment Corp Units
FICVU
$146K ﹤0.01%
15,026
-150
-1% -$1.47K
ARRY icon
1342
Array Technologies
ARRY
$819M
$144K ﹤0.01%
+13,101
New +$129K
GENI icon
1343
Genius Sports
GENI
$2.1B
$144K ﹤0.01%
63,838
+24,973
+64% +$84.2K
CGC
1344
Canopy Growth
CGC
$402M
$143K ﹤0.01%
5,000
NOK icon
1345
CALL
Nokia
NOK
$51B
$143K ﹤0.01%
31,000
-7,000
-18% -$35K
ENVX icon
1346
Enovix
ENVX
$1.01B
$141K ﹤0.01%
+18,150
New +$171K
IIM icon
1347
Invesco Value Municipal Income Trust
IIM
$595M
$139K ﹤0.01%
+10,800
New +$142K
VTNR
1348
DELISTED
Vertex Energy, Inc
VTNR
$139K ﹤0.01%
13,237
-31,057
-70% -$368K
GDRX icon
1349
GoodRx Holdings
GDRX
$1.25B
$138K ﹤0.01%
+23,341
New +$260K
SVFB
1350
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$138K ﹤0.01%
14,068
-150,449
-91% -$1.47M

Similar funds

Prelude Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Prelude Capital Management held 2,292 positions worth $3.52B, up 1% from $3.48B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Prelude Capital Management deployed $831M of net new capital in Q2 2022, opening 549 new positions and adding to 398 existing holdings. Its largest new stake was SM Energy: 2,001,257 shares worth $1.94M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was TSMC, an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q2 2022 buy was SM Energy: 2,001,257 shares worth $1.94M.
  • Prelude Capital Management added most to Lockheed Martin in Q2 2022, an estimated $85.8M increase.
  • Prelude Capital Management's biggest Q2 2022 reduction was TSMC, cutting an estimated $13.2M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q2 2022, selling an estimated $42M.
  • Prelude Capital Management's ten largest holdings make up 38% of its $3.52B portfolio in Q2 2022.
  • Prelude Capital Management opened 549 new positions and closed 501 in Q2 2022.
  • Prelude Capital Management's portfolio value rose 1% quarter-over-quarter to $3.52B.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.